- Y Diweddaraf sydd Ar Gael (Diwygiedig)
- Pwynt Penodol mewn Amser (23/09/2013)
- Gwreiddiol (Fel y’i mabwysiadwyd gan yr UE)
Regulation (EU) No 528/2012 of the European Parliament and of the Council of 22 May 2012 concerning the making available on the market and use of biocidal products (Text with EEA relevance)
When the UK left the EU, legislation.gov.uk published EU legislation that had been published by the EU up to IP completion day (31 December 2020 11.00 p.m.). On legislation.gov.uk, these items of legislation are kept up-to-date with any amendments made by the UK since then.
Mae unrhyw newidiadau sydd wedi cael eu gwneud yn barod gan y tîm yn ymddangos yn y cynnwys a chyfeirir atynt gydag anodiadau.Ar ôl y diwrnod ymadael bydd tair fersiwn o’r ddeddfwriaeth yma i’w gwirio at ddibenion gwahanol. Y fersiwn legislation.gov.uk yw’r fersiwn sy’n weithredol yn y Deyrnas Unedig. Y Fersiwn UE sydd ar EUR-lex ar hyn o bryd yw’r fersiwn sy’n weithredol yn yr UE h.y. efallai y bydd arnoch angen y fersiwn hon os byddwch yn gweithredu busnes yn yr UE. EUR-Lex Y fersiwn yn yr archif ar y we yw’r fersiwn swyddogol o’r ddeddfwriaeth fel yr oedd ar y diwrnod ymadael cyn cael ei chyhoeddi ar legislation.gov.uk ac unrhyw newidiadau ac effeithiau a weithredwyd yn y Deyrnas Unedig wedyn. Mae’r archif ar y we hefyd yn cynnwys cyfraith achos a ffurfiau mewn ieithoedd eraill o EUR-Lex. The EU Exit Web Archive legislation_originated_from_EU_p3
There are currently no known outstanding effects for the Regulation (EU) No 528/2012 of the European Parliament and of the Council.
Revised legislation carried on this site may not be fully up to date. At the current time any known changes or effects made by subsequent legislation have been applied to the text of the legislation you are viewing by the editorial team. Please see ‘Frequently Asked Questions’ for details regarding the timescales for which new effects are identified and recorded on this site.
CHAPTER III RENEWAL AND REVIEW OF APPROVAL OF AN ACTIVE SUBSTANCE
CHAPTER IV GENERAL PRINCIPLES CONCERNING THE AUTHORISATION OF BIOCIDAL PRODUCTS
CHAPTER VIII UNION AUTHORISATIONS OF BIOCIDAL PRODUCTS
CHAPTER IX CANCELLATION, REVIEW AND AMENDMENT OF AUTHORISATIONS
CHAPTER XV INFORMATION AND COMMUNICATION
Article 86.Active substances included in Annex I to Directive 98/8/EC
Article 90.Transitional measures concerning active substances evaluated under Directive 98/8/EC
Article 91.Transitional measures concerning applications for biocidal product authorisations submitted under Directive 98/8/EC
Article 92.Transitional measures concerning biocidal products authorised/registered under Directive 98/8/EC
Article 93.Transitional measures concerning biocidal products not covered by the scope of Directive 98/8/EC
Article 94.Transitional measures concerning treated articles
Article 95.Transitional measures concerning access to the active substance dossier
INFORMATION REQUIREMENTS FOR ACTIVE SUBSTANCES
1. This Annex sets out the information requirements for the preparation...
3. A detailed and full description of the studies conducted or...
6. Tests performed should comply with the relevant requirements of protection...
7. Where testing is done, a detailed description (specification) of the...
8. Where test data exist that have been generated before 1...
9. New tests involving vertebrates shall be conducted as the last...
INFORMATION REQUIREMENTS FOR BIOCIDAL PRODUCTS
1. This Annex sets out the information requirements that shall be...
3. A detailed and full description of studies conducted and of...
4. The formats made available by the Agency shall be used...
5. Tests submitted for the purpose of authorisation shall be conducted...
6. Tests performed should comply with the relevant requirements of protection...
7. Where testing is done, a detailed quantitative and qualitative description...
8. Where test data exist that have been generated before 17...
9. New tests involving vertebrates shall be conducted as the last...
BIOCIDAL PRODUCT-TYPES AND THEIR DESCRIPTIONS AS REFERRED TO IN ARTICLE ...
COMMON PRINCIPLES FOR THE EVALUATION OF DOSSIERS FOR BIOCIDAL PRODUCTS
1. This Annex sets out the common principles for the evaluation...
4. A risk assessment on the active substance(s) present in the...
5. Additional risk assessments shall be carried out, in the same...
7. The results of the risk assessments carried out on the...
8. When making evaluations of a biocidal product the evaluating body...
9. The application of these common principles shall, when taken together...
10. In the case of biocidal products containing active substances covered...
11. During the process of evaluation, applicants and the evaluating bodies...
12. The judgments made by the evaluating body during the evaluation...
13. The data submitted in support of an application for authorisation...
14. A risk assessment on the active substance present in the...
15. In carrying out the assessment, the possibility of cumulative or...
16. For each active substance and each substance of concern present...
17. The results arrived at from a comparison of the exposure...
19. In certain cases it may be concluded that further data...
20. The information provided on the biocidal product family shall permit...
21. Where relevant the technical equivalence for every active substance contained...
Effects on human and animal health
22. The risk assessment shall take account of the following potential...
23. The effects previously mentioned result from the properties of the...
25. The hazard identification shall address the properties and potential adverse...
27. For repeated dose toxicity and reproductive toxicity the dose-response relationship...
28. For acute toxicity, corrosivity and irritation, it is not usually...
29. For mutagenicity and carcinogenicity, a non-threshold assessment should be carried...
30. With respect to skin sensitisation and respiratory sensitisation, in so...
31. When carrying out the risk assessment special consideration shall be...
32. An exposure assessment shall be carried out for each of...
33. The exposure assessment shall be based on the information in...
34. When conducting the exposure assessment, special consideration shall be given...
37. The risk assessment shall take account of any adverse effects...
38. The hazard identification shall address the properties and potential adverse...
39. A dose (concentration) — response (effect) assessment shall be carried...
40. The PNEC shall be determined from the data on effects...
41. An assessment factor is an expression of the degree of...
42. For each environmental compartment, an exposure assessment shall be carried...
43. A PEC, or where necessary a qualitative estimate of exposure,...
44. The PEC, or the qualitative estimation of exposure, shall be...
45. When conducting the exposure assessment, special consideration shall be given...
46. For any given environmental compartment, the risk characterisation shall, as...
48. The evaluating body shall conclude that the biocidal product does...
Effects on human and animal health
59. The evaluating body shall consider possible effects on all human...
60. The evaluating body shall examine the relationship between exposure and...
61. Typically, the margin of exposure (MOEref) — the ratio between...
62. The evaluating body shall, where appropriate, conclude that criterion (iii)...
63. If, for non-professional users, the wearing of personal protective equipment...
The Whole Regulation you have selected contains over 200 provisions and might take some time to download. You may also experience some issues with your browser, such as an alert box that a script is taking a long time to run.
Would you like to continue?
Y Rhestrau you have selected contains over 200 provisions and might take some time to download. You may also experience some issues with your browser, such as an alert box that a script is taking a long time to run.
Would you like to continue?
Y Diweddaraf sydd Ar Gael (diwygiedig):Y fersiwn ddiweddaraf sydd ar gael o’r ddeddfwriaeth yn cynnwys newidiadau a wnaed gan ddeddfwriaeth ddilynol ac wedi eu gweithredu gan ein tîm golygyddol. Gellir gweld y newidiadau nad ydym wedi eu gweithredu i’r testun eto yn yr ardal ‘Newidiadau i Ddeddfwriaeth’.
Gwreiddiol (Fel y’i mabwysiadwyd gan yr UE): Mae'r wreiddiol version of the legislation as it stood when it was first adopted in the EU. No changes have been applied to the text.
Pwynt Penodol mewn Amser: This becomes available after navigating to view revised legislation as it stood at a certain point in time via Advanced Features > Show Timeline of Changes or via a point in time advanced search.
Gallwch wneud defnydd o ddogfennau atodol hanfodol a gwybodaeth ar gyfer yr eitem ddeddfwriaeth o’r tab hwn. Yn ddibynnol ar yr eitem ddeddfwriaeth sydd i’w gweld, gallai hyn gynnwys:
Mae’r llinell amser yma yn dangos y fersiynau gwahanol a gymerwyd o EUR-Lex yn ogystal ag unrhyw fersiynau dilynol a grëwyd ar ôl y diwrnod ymadael o ganlyniad i newidiadau a wnaed gan ddeddfwriaeth y Deyrnas Unedig.
Cymerir dyddiadau fersiynau’r UE o ddyddiadau’r dogfennau ar EUR-Lex ac efallai na fyddant yn cyfateb â’r adeg pan ddaeth y newidiadau i rym ar gyfer y ddogfen.
Ar gyfer unrhyw fersiynau a grëwyd ar ôl y diwrnod ymadael o ganlyniad i newidiadau a wnaed gan ddeddfwriaeth y Deyrnas Unedig, bydd y dyddiad yn cyd-fynd â’r dyddiad cynharaf y daeth y newid (e.e. ychwanegiad, diddymiad neu gyfnewidiad) a weithredwyd i rym. Am ragor o wybodaeth gweler ein canllaw i ddeddfwriaeth ddiwygiedig ar Ddeall Deddfwriaeth.
Defnyddiwch y ddewislen hon i agor dogfennau hanfodol sy’n cyd-fynd â’r ddeddfwriaeth a gwybodaeth am yr eitem hon o ddeddfwriaeth. Gan ddibynnu ar yr eitem o ddeddfwriaeth sy’n cael ei gweld gall hyn gynnwys:
liciwch ‘Gweld Mwy’ neu ddewis ‘Rhagor o Adnoddau’ am wybodaeth ychwanegol gan gynnwys